A1 Refereed original research article in a scientific journal

Childhood 25-hydroxy-vitamin D levels predict early cardiovascular outcomes in adulthood: the Cardiovascular Risk in Young Finns Study




AuthorsNiemelä, Jussi; Laitinen, Tomi T.; Nuotio, Joel; Pahkala, Katja; Rovio, Suvi; Viikari, Jorma; Kähönen, Mika; Lehtimäki, Terho; Loo, Britt-Marie; Laitinen, Tomi P.; Jokinen, Eero; Tossavainen, Päivi; Magnussen, Costan G.; Juonala, Markus; Raitakari, Olli

PublisherOxford University Press

Publication year2025

Journal: European Journal of Preventive Cardiology

ISSN2047-4873

eISSN2047-4881

DOIhttps://doi.org/10.1093/eurjpc/zwaf271

Publication's open availability at the time of reportingOpen Access

Publication channel's open availability Partially Open Access publication channel

Web address https://doi.org/10.1093/eurjpc/zwaf271

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/505618726



Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Funding information in the publication
The Young Finns Study has been financially supported by the Academy of Finland: grants 322098, 286284, 134309 (Eye), 126925, 121584, 124282, 255381, 256474, 283115, 319060, 320297, 314389, 338395, 330809, 104821, 129378 (Salve), 117797 (Gendi), and 141071 (Skidi); the Social Insurance Institution of Finland; Competitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere and Turku University Hospitals (grant X51001); Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; The Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjö Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Diabetes Research Foundation of Finnish Diabetes Association; EU Horizon 2020 (grant 755320 for TAXINOMISIS and grant 848146 for to Aition); European Research Council (grant 742927 for MULTIEPIGEN project); and Tampere University Hospital Supporting Foundation, Finnish Society of Clinical Chemistry, and the Cancer Foundation Finland. J.N. was funded by Finnish Cultural Foundation, Varsinais-Suomi Regional Fund, and the EVO fund of Turku University Hospital. K.P. was funded by the Academy of Finland Research Fellowship (no. 322112). T.T.L. was funded by The Sakari Alhopuro Foundation.


Last updated on 09/01/2026 01:42:20 PM